Project Grant G2649919

Federal Project Grant Award Summary The Rural Communities Opioid Response Program-Overdose Response grant, administered by the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912), awarded $300,000 to New Horizons Community Service Board for a 12-month project period beginning September 1, 2025. The project, titled "Closing the Gaps in SOWEGA," delivers direct prevention, treatment, and recovery services addressing substance use disorder...

This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...

Federal Grant Award Summary ST. Francis House Nwa, Inc., doing business as Community Clinic, received a $600,000 Project Grant award dated September 1, 2025, through the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912) to implement the Rural Communities Opioid Response Program-Overdose Response (RCORP-OR) initiative. The 12-month project, concluding August 31, 2026, targets opioid overdose reduction in rural Benton County, Arkansas, and Delaware...

The National Institute on Drug Abuse (NIDA) awarded The Washington University a 3-year, $2,337,729 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to study the impact of prenatal opioid exposure on placental and fetal brain development. The project, titled "The Opioid in Pregnancy: Imaging of Oxygenation, Inflammation, and Development in Brain & Placenta" (OPIOID BPP), aims to define the longitudinal effects of prenatal opioid exposure on...

Federal Grant Award Summary The Federal Office of Rural Health Policy awarded $1.2 million to the New England Rural Health Association, Inc. (NERHA) under the Rural Healthcare Services Programs (CFDA 93.912) through a Project Grant mechanism. The award, effective September 1, 2025, through August 31, 2029, funds the Rural Communities Opioid Response Program – Northern Border Rural Workforce initiative, which serves rural communities across New England. NERHA will deliver services and support...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA 93.279 Drug Use and Addiction Research Programs, provides $3,503,736 to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) to develop and test a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county juvenile court systems. The project aims to collaboratively co-design the prevention strategy and an implementation...

Federal Grant Award Summary The Naloxone Project (TNP) received a $600,000 Project Grant award dated September 1, 2025, from the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912) to implement the Colorado Coalition for Harm Reduction, Access to Naloxone, and Grassroots Rural Engagement (Colorado CHANGE) Project. Operating across 118 rural provider sites in Colorado including emergency departments, labor and delivery units, and outpatient clinics,...

This Project Grant award, funded by the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program, supports a comprehensive $398,972 study on improving healthcare quality and equity for newborns with prenatal substance exposure. The study, conducted by the University of California, Davis in collaboration with the Better Outcomes through Research for Newborns (BORN) network and the EMPOWER stakeholder group, aims to:...

The National Institute on Drug Abuse (NIDA) awarded a $411,800 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Rekovar Inc., a women-owned small business based in California. The grant, awarded on February 1, 2025, supports the development of NeoMonki, a wireless wearable system with AI-driven analytics for monitoring and assessing Neonatal Abstinence Syndrome (NAS). NeoMonki consists of wearable biosensor wristbands, a tablet-based healthcare portal, a charging...

Federal Grant Award Summary Rio Arriba County received a $600,000 Project Grant from the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912) for the period of September 1, 2025, through August 31, 2026. The award supports the Rural Communities Opioid Response Program-Overdose Response initiative, which addresses New Mexico's critically elevated drug overdose mortality rate of 49 per 100,000 people—50% above the national rate of 32.9 per 100,000. Rio...